7jyr › Citations

Discovery of Novel and Highly Selective Cyclopropane ALK Inhibitors through a Fragment-Assisted, Structure-Based Drug Design.

Figure 1
Figure 2
Figure 3
Fujimori I, Wakabayashi T, Murakami M, Okabe A, Ishii T, McGrath A, Zou H, Saikatendu KS, Imoto H
OpenAccess logo ACS Omega 5 31984-32001 (2020)
Related entries: 7jy4, 7jys, 7jyt

Cited: 2 times
EuropePMC logo PMID: 33344853

Abstract

Fragment screening is frequently used for hit identification. However, there was no report starting from a small fragment for the development of an anaplastic lymphoma kinase (ALK) inhibitor, despite the number of ALK inhibitors reported. We began our research with the fragment hit

Articles - 7jyr mentioned but not cited (1)

  1. Discovery of Novel and Highly Selective Cyclopropane ALK Inhibitors through a Fragment-Assisted, Structure-Based Drug Design. Fujimori I, Wakabayashi T, Murakami M, Okabe A, Ishii T, McGrath A, Zou H, Saikatendu KS, Imoto H. ACS Omega 5 31984-32001 (2020)


Reviews citing this publication (1)

  1. Fragment-to-Lead Medicinal Chemistry Publications in 2020. de Esch IJP, Erlanson DA, Jahnke W, Johnson CN, Walsh L. J Med Chem 65 84-99 (2022)


Quick links